Rational design of B-cell and T-cell multi epitope-based vaccine against Zika virus, an in silico study

References

• Agostini, F., Cirillo, D., Livi, C. M., Delli Ponti, R., & Tartaglia, G. G. (2014). cc SOL omics: A webserver for solubility prediction of endogenous and heterologous expression in Escherichia coli. Bioinformatics (Oxford, England), 30(20), 2975–2977. https://doi.org/10.1093/bioinformatics/btu420
   PubMed Web of Science ®Google Scholar
• Alam, A., Ali, S., Ahamad, S., Malik, M. Z., & Ishrat, R. (2016). From ZikV genome to vaccine: In silico approach for the epitope‐based peptide vaccine against Zika virus envelope glycoprotein. Immunology, 149(4), 386–399. https://doi.org/10.1111/imm.12656
   PubMed Web of Science ®Google Scholar
• AlChalabi, R., Al-Rahim, A., Omer, D., & Suleiman, A. A. (2023). Immunoinformatics design of multi-epitope peptide-based vaccine against Haemophilus influenzae strain using cell division protein. Network Modeling and Analysis in Health Informatics and Bioinformatics, 12(1), 1. https://doi.org/10.1007/s13721-022-00395-x
   PubMed Web of Science ®Google Scholar
• Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990). Basic local alignment search tool. Journal of Molecular Biology, 215(3), 403–410. https://doi.org/10.1016/S0022-2836(05)80360-2
   PubMed Web of Science ®Google Scholar
• Amaral, M. P., de Souza Apostolico, J., Tomita, N., Coirada, F. C., Lunardelli, V. A. S., Fernandes, E. R., Souza, H. F. S., Astray, R. M., Boscardin, S. B., & Rosa, D. S. (2020). Homologous prime-boost with Zika virus envelope protein and poly (I: C) induces robust specific humoral and cellular immune responses. Vaccine, 38(20), 3653–3664. https://doi.org/10.1016/j.vaccine.2020.03.037
   PubMed Web of Science ®Google Scholar
• Antonelli, A. C. B., Almeida, V. P., de Castro, F. O. F., Silva, J. M., Pfrimer, I. A. H., Cunha-Neto, E., Maranhão, A. Q., Brígido, M. M., Resende, R. O., Bocca, A. L., & Fonseca, S. G. (2022). In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools. Scientific Reports, 12(1), 53. https://doi.org/10.1038/s41598-021-03990-6
   PubMed Web of Science ®Google Scholar
• Ashfaq, U. A., & Ahmed, B. (2016). De novo structural modeling and conserved epitopes prediction of Zika virus envelop protein for vaccine development. Viral Immunology, 29(7), 436–443. https://doi.org/10.1089/vim.2016.0033
   PubMed Web of Science ®Google Scholar
• Athanasiou, E., Agallou, M., Tastsoglou, S., Kammona, O., Hatzigeorgiou, A., Kiparissides, C., & Karagouni, E. (2017). A poly (lactic-co-glycolic) acid nanovaccine based on chimeric peptides from different Leishmania infantum proteins induces dendritic cells maturation and promotes peptide-specific IFNγ-producing CD8+ T cells essential for the protection against experimen. Frontiers in Immunology, 8, 684. https://doi.org/10.3389/fimmu.2017.00684
   PubMed Web of Science ®Google Scholar
• Awasthi, S., Hook, L. M., Swaminathan, G., Cairns, T. M., Brooks, B., Smith, J. S., Ditto, N. T., Gindy, M. E., Bett, A. J., Espeseth, A. S., Cohen, G. H., & Friedman, H. M. (2019). Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants. Vaccine, 37(29), 3770–3778. https://doi.org/10.1016/j.vaccine.2019.05.068
   PubMed Web of Science ®Google Scholar
• Bhattacharya, D., Nowotny, J., Cao, R., & Cheng, J. (2016). 3Drefine: An interactive web server for efficient protein structure refinement. Nucleic Acids Research, 44(W1), W406–W409. https://doi.org/10.1093/nar/gkw336
   PubMed Web of Science ®Google Scholar
• Buathong, R., Hermann, L., Thaisomboonsuk, B., Rutvisuttinunt, W., Klungthong, C., Chinnawirotpisan, P., Manasatienkij, W., Nisalak, A., Fernandez, S., Yoon, I.-K., Akrasewi, P., & Plipat, T. (2015). Detection of Zika virus infection in Thailand, 2012–2014. The American Journal of Tropical Medicine and Hygiene, 93(2), 380–383. https://doi.org/10.4269/ajtmh.15-0022
   PubMed Web of Science ®Google Scholar
• Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009). BLAST+: Architecture and applications. BMC Bioinformatics, 10(1), 9. https://doi.org/10.1186/1471-2105-10-421
   PubMedGoogle Scholar
• Castiglione, F., Deb, D., Srivastava, A. P., Liò, P., & Liso, A. (2021). From infection to immunity: Understanding the response to SARS-CoV2 through in-silico modeling. Frontiers in Immunology, 12, 646972. https://doi.org/10.3389/fimmu.2021.646972
   PubMedGoogle Scholar
• Castiglione, F., Duca, K., Jarrah, A., Laubenbacher, R., Hochberg, D., & Thorley-Lawson, D. (2007). Simulating epstein-barr virus infection with c-immsim. Bioinformatics (Oxford, England), 23(11), 1371–1377. https://doi.org/10.1093/bioinformatics/btm044
   PubMed Web of Science ®Google Scholar
• Choudhry, H., Alzahrani, F. A., Hassan, M. A., Alghamdi, A., Abdulaal, W. H., Bakhrebah, M. A., Zamzami, M. A., Helmi, N., Bokhari, F. F., Zeyadi, M., Baothman, O. A., Kamal, M. A., Warsi, M. K., Ali, A., Jarullah, B., & Jamal, M. S. (2019). Zika virus targeting by screening inhibitors against NS2B/NS3 protease. BioMed Research International, 2019, 1–11. https://doi.org/10.1155/2019/3947245
   Web of Science ®Google Scholar
• Da Conceicao, P. J. P., De Carvalho, L. R., De Godoy, B. L. V., Nogueira, M. L., Terzian, A. C. B., de Godoy, M. F., Calmon, M. F., Bittar, C., & Rahal, P. (2022). Detection of Zika virus in urine from randomly tested individuals in Mirassol, Brazil. Infection, 50(1), 149–156. https://doi.org/10.1007/s15010-021-01667-w
   PubMed Web of Science ®Google Scholar
• Desta, I. T., Porter, K. A., Xia, B., Kozakov, D., & Vajda, S. (2020). Performance and its limits in rigid body protein-protein docking. Structure (London, England : 1993), 28(9), 1071–1081.e3. https://doi.org/10.1016/j.str.2020.06.006
   PubMed Web of Science ®Google Scholar
• Dick, G. W. A., Kitchen, S. F., & Haddow, A. J. (1952). Zika virus (I). Isolations and serological specificity. Transactions of the Royal Society of Tropical Medicine and Hygiene, 46(5), 509–520. https://doi.org/10.1016/0035-9203(52)90042-4
   PubMed Web of Science ®Google Scholar
• Dimitrov, I., Bangov, I., Flower, D. R., & Doytchinova, I. (2014). AllerTOP v. 2—a server for in silico prediction of allergens. Journal of Molecular Modeling, 20(6) https://doi.org/10.1007/s00894-014-2278-5
   PubMed Web of Science ®Google Scholar
• dos Santos Franco, L., Oliveira Vidal, P., & Amorim, J. H. (2017). In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations. Journal of Biomedical Science, 24(1), 10. https://doi.org/10.1186/s12929-017-0395-z
   PubMedGoogle Scholar
• Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8(1), 1–7. https://doi.org/10.1186/1471-2105-8-4
   PubMedGoogle Scholar
• Duffy, M. R., Chen, T.-H., Hancock, W. T., Powers, A. M., Kool, J. L., Lanciotti, R. S., Pretrick, M., Marfel, M., Holzbauer, S., Dubray, C., Guillaumot, L., Griggs, A., Bel, M., Lambert, A. J., Laven, J., Kosoy, O., Panella, A., Biggerstaff, B. J., Fischer, M., & Hayes, E. B. (2009). Zika virus outbreak on Yap Island, federated states of Micronesia. The New England Journal of Medicine, 360(24), 2536–2543. https://doi.org/10.1056/NEJMoa0805715
   PubMed Web of Science ®Google Scholar
• Durbin, A. P. (2016). Vaccine development for Zika virus—timelines and strategies. Seminars in Reproductive Medicine, 34(5), 299–304. https://doi.org/10.1055/s-0036-1592070
   PubMed Web of Science ®Google Scholar
• Durbin, A. P., & Whitehead, S. S. (2017). Zika vaccines: Role for controlled human infection. The Journal of Infectious Diseases, 216(suppl_10), S971–S975. https://doi.org/10.1093/infdis/jix491
   PubMedGoogle Scholar
• Ezzemani, W., Windisch, M. P., Altawalah, H., Guessous, F., Saile, R., Benjelloun, S., Kettani, A., & Ezzikouri, S. (2022). Design of a multi-epitope Zika virus vaccine candidate–an in-silico study. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2022.2055648
   Google Scholar
• Fatima, I., Ahmad, S., Abbasi, S. W., Ashfaq, U. A., Shahid, F., Ul Qamar, M. T., Rehman, A., & Allemailem, K. S. (2022). Designing of a multi-epitopes-based peptide vaccine against rift valley fever virus and its validation through integrated computational approaches. Computers in Biology and Medicine, 141, 105151. https://doi.org/10.1016/j.compbiomed.2021.105151
   PubMed Web of Science ®Google Scholar
• Faye, O., Freire, C. C. M., Iamarino, A., Faye, O., de Oliveira, J. V. C., Diallo, M., Zanotto, P. M. A., & Sall, A. A. (2014). Molecular evolution of Zika virus during its emergence in the 20th century. PLoS Neglected Tropical Diseases, 8(1), e2636. https://doi.org/10.1371/journal.pntd.0002636
   PubMed Web of Science ®Google Scholar
• Foy, B. D., Kobylinski, K. C., Foy, J. L. C., Blitvich, B. J., da Rosa, A. T., Haddow, A. D., Lanciotti, R. S., & Tesh, R. B. (2011). Probable non–vector-borne transmission of Zika virus, Colorado, USA. Emerging Infectious Diseases, 17(5), 880–882. https://doi.org/10.3201/eid1705.101939
   PubMed Web of Science ®Google Scholar
• Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., Appel, R. D., & Bairoch, A. (2003). ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Research, 31(13), 3784–3788. https://doi.org/10.1093/nar/gkg563
   PubMed Web of Science ®Google Scholar
• Gul, S., Ahmad, S., Ullah, A., Ismail, S., Khurram, M., Tahir Ul Qamar, M., Hakami, A. R., Alkhathami, A. G., Alrumaihi, F., & Allemailem, K. S. (2022). Designing a recombinant vaccine against Providencia rettgeri using immunoinformatics approach. Vaccines, 10(2), 189. https://doi.org/10.3390/vaccines10020189
   Web of Science ®Google Scholar
• Hemmi, H., Kaisho, T., Takeda, K., & Akira, S. (2003). The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. Journal of Immunology (Baltimore, Md. : 1950), 170(6), 3059–3064. https://doi.org/10.4049/jimmunol.170.6.3059
   PubMed Web of Science ®Google Scholar
• Ikram, A., Zaheer, T., Awan, F. M., Obaid, A., Naz, A., Hanif, R., Paracha, R. Z., Ali, A., Naveed, A. K., & Janjua, H. A. (2018). Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches. Scientific Reports, 8(1), 1–14. https://doi.org/10.1038/s41598-018-34254-5
   PubMed Web of Science ®Google Scholar
• Jahantigh, H. R., Stufano, A., Lovreglio, P., Rezaee, S. A., & Ahmadi, K. (2022). In silico identification of epitope-based vaccine candidates against HTLV-1. Journal of Biomolecular Structure & Dynamics, 40(15), 6737–6754. https://doi.org/10.1080/07391102.2021.1889669
   PubMed Web of Science ®Google Scholar
• Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018). Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology, 154(3), 394–406. https://doi.org/10.1111/imm.12889
   PubMed Web of Science ®Google Scholar
• Krishnan, S., Joshi, A., Akhtar, N., & Kaushik, V. (2021). Immunoinformatics designed T cell multi epitope dengue peptide vaccine derived from non structural proteome. Microbial Pathogenesis, 150, 104728. https://doi.org/10.1016/j.micpath.2020.104728
   PubMed Web of Science ®Google Scholar
• Kumar Pandey, R., Ojha, R., Mishra, A., & Kumar Prajapati, V. (2018). Designing B‐and T‐cell multi‐epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection. Journal of Cellular Biochemistry, 119(9), 7631–7642. https://doi.org/10.1002/jcb.27110
   PubMed Web of Science ®Google Scholar
• Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., & Nielsen, M. (2007). Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics, 8(1), 12. https://doi.org/10.1186/1471-2105-8-424
   PubMedGoogle Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., & Thornton, J. M. (2006). PROCHECK: Validation of protein-structure coordinates.
   Google Scholar
• Laskowski, R. A., Rullmann, J. A. C., MacArthur, M. W., Kaptein, R., & Thornton, J. M. (1996). AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. Journal of Biomolecular NMR, 8(4), 477–486. https://doi.org/10.1007/BF00228148
   PubMed Web of Science ®Google Scholar
• Lima, N. S., Moon, D., Darko, S., De La Barrera, R. A., Lin, L., Koren, M. A., Jarman, R. G., Eckels, K. H., Thomas, S. J., Michael, N. L., Modjarrad, K., Douek, D. C., & Trautmann, L. (2021). Pre-existing immunity to Japanese encephalitis virus alters CD4 T cell responses to Zika virus inactivated vaccine. Frontiers in Immunology, 12, 640190. https://doi.org/10.3389/fimmu.2021.640190
   PubMed Web of Science ®Google Scholar
• Magnan, C. N., Randall, A., & Baldi, P. (2009). SOLpro: Accurate sequence-based prediction of protein solubility. Bioinformatics (Oxford, England), 25(17), 2200–2207. https://doi.org/10.1093/bioinformatics/btp386
   PubMed Web of Science ®Google Scholar
• Majerová, T., Novotný, P., Krýsová, E., & Konvalinka, J. (2019). Exploiting the unique features of Zika and Dengue proteases for inhibitor design. Biochimie, 166, 132–141. https://doi.org/10.1016/j.biochi.2019.05.004
   PubMed Web of Science ®Google Scholar
• Martins, I. C., Ricardo, R. C., & Santos, N. C. (2022). Dengue, west Nile, and Zika viruses: Potential novel antiviral biologics drugs currently at discovery and preclinical development stages. Pharmaceutics, 14(11), 2535. https://doi.org/10.3390/pharmaceutics14112535
   PubMed Web of Science ®Google Scholar
• Mekonnen, D., Mengist, H. M., & Jin, T. (2022). SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways. Expert Review of Vaccines, 21(1), 69–81. https://doi.org/10.1080/14760584.2021.1991794
   PubMed Web of Science ®Google Scholar
• Mota, M. L., dos Santos Souza Marinho, R., Duro, R. L. S., Hunter, J., de Menezes, I. R. A., de Lima Silva, J. M. F., Pereira, G. L. T., Sabino, E. C., Grumach, A., Diaz, R. S., do Socorro Lucena, M., & Komninakis, S. V. (2021). Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil. BMC Infectious Diseases, 21(1), 1–7. https://doi.org/10.1186/s12879-021-06401-3
   PubMed Web of Science ®Google Scholar
• Musso, D., & Gubler, D. J. (2016). Zika virus. Clinical Microbiology Reviews, 29(3), 487–524. https://doi.org/10.1128/CMR.00072-15
   PubMed Web of Science ®Google Scholar
• Naveed, M., Tehreem, S., Arshad, S., Bukhari, S. A., Shabbir, M. A., Essa, R., Ali, N., Zaib, S., Khan, A., Al-Harrasi, A., & Khan, I. (2021). Design of a novel multiple epitope-based vaccine: An immunoinformatics approach to combat SARS-CoV-2 strains. Journal of Infection and Public Health, 14(7), 938–946. https://doi.org/10.1016/j.jiph.2021.04.010
   PubMed Web of Science ®Google Scholar
• Parvizpour, S., Pourseif, M. M., Razmara, J., Rafi, M. A., & Omidi, Y. (2020). Epitope-based vaccine design: A comprehensive overview of bioinformatics approaches. Drug Discovery Today, 25(6), 1034–1042. https://doi.org/10.1016/j.drudis.2020.03.006
   PubMed Web of Science ®Google Scholar
• Pattnaik, A., Sahoo, B. R., & Pattnaik, A. K. (2020). Current status of Zika virus vaccines: Successes and challenges. Vaccines, 8(2), 266. https://doi.org/10.3390/vaccines8020266
   Web of Science ®Google Scholar
• Petersen, L. R., & Cassetti, M. C. (2020). Learning about Zika virus epidemiology and diagnostics from blood donor studies. The Lancet. Infectious Diseases, 20(12), 1357–1359. https://doi.org/10.1016/S1473-3099(20)30125-0
   PubMed Web of Science ®Google Scholar
• Phatihattakorn, C., Wongsa, A., Pongpan, K., Anuwuthinawin, S., Mungmanthong, S., Wongprasert, M., & Tassaneetrithep, B. (2021). Seroprevalence of Zika virus in pregnant women from central Thailand. PloS One, 16(9), e0257205. https://doi.org/10.1371/journal.pone.0257205
   PubMed Web of Science ®Google Scholar
• Poland, G. A., Kennedy, R. B., Ovsyannikova, I. G., Palacios, R., Ho, P. L., & Kalil, J. (2018). Development of vaccines against Zika virus. The Lancet. Infectious Diseases, 18(7), e211–e219. https://doi.org/10.1016/S1473-3099(18)30063-X
   PubMed Web of Science ®Google Scholar
• Ponomarenko, J., Bui, H.-H., Li, W., Fusseder, N., Bourne, P. E., Sette, A., & Peters, B. (2008). ElliPro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics, 9(1), 8. https://doi.org/10.1186/1471-2105-9-514
   PubMedGoogle Scholar
• Prasasty, V. D., Grazzolie, K., Rosmalena, R., Yazid, F., Ivan, F. X., & Sinaga, E. (2019). Peptide-based subunit vaccine design of T-and B-cells multi-epitopes against Zika virus using immunoinformatics approaches. Microorganisms, 7(8), 226. https://doi.org/10.3390/microorganisms7080226
   PubMed Web of Science ®Google Scholar
• Rahmani, A., Baee, M., Rostamtabar, M., Karkhah, A., Alizadeh, S., Tourani, M., & Nouri, H. R. (2019). Development of a conserved chimeric vaccine based on helper T-cell and CTL epitopes for induction of strong immune response against Schistosoma mansoni using immunoinformatics approaches. International Journal of Biological Macromolecules, 141, 125–136. https://doi.org/10.1016/j.ijbiomac.2019.08.259
   PubMed Web of Science ®Google Scholar
• Ranjbar, M. M., Ebrahimi, M. M., Shahsavandi, S., Farhadi, T., Mirjalili, A., Tebianian, M., & Motedayen, M. H. (2019). Novel applications of immuno-bioinformatics in vaccine and bio-product developments at research institutes. Archives of Razi Institute, 74(3), 219–233.
   PubMedGoogle Scholar
• Rapin, N., Lund, O., Bernaschi, M., & Castiglione, F. (2010). Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PloS One, 5(4), e9862. https://doi.org/10.1371/journal.pone.0009862
   PubMed Web of Science ®Google Scholar
• Rice, P., Longden, I., & Bleasby, A. (2000). EMBOSS: The European molecular biology open software suite. Trends in Genetics : TIG, 16(6), 276–277. https://doi.org/10.1016/s0168-9525(00)02024-2
   PubMed Web of Science ®Google Scholar
• Richner, J. M., & Diamond, M. S. (2018). Zika virus vaccines: Immune response, current status, and future challenges. Current Opinion in Immunology, 53, 130–136. https://doi.org/10.1016/j.coi.2018.04.024
   PubMed Web of Science ®Google Scholar
• Rodríguez-Morales, A. J., Bonilla-Aldana, D. K., Bonilla-Aldana, J. L., Arteaga-Livias, K., Pecho-Silva, S., & Escalera-Antezana, J. P. (2021). Role of Zika virus infection in cases and outbreaks of Guillain-Barré syndrome in Latin America: Pooling the prevalence of studies. Travel Medicine and Infectious Disease, 39, 101905. https://doi.org/10.1016/j.tmaid.2020.101905
   PubMed Web of Science ®Google Scholar
• Saha, S., & Raghava, G. P. S. (2006). Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network. Proteins, 65(1), 40–48. https://doi.org/10.1002/prot.21078
   PubMed Web of Science ®Google Scholar
• Saha, S., & Raghava, G. P. S. (2007). Prediction methods for B-cell epitopes. Immunoinformatics: Predicting Immunogenicity In Silico. 387–394.
   Google Scholar
• Saisawang, C., Kuadkitkan, A., Auewarakul, P., Smith, D. R., & Ketterman, A. J. (2018). Glutathionylation of dengue and Zika NS5 proteins affects guanylyltransferase and RNA dependent RNA polymerase activities. PloS One, 13(2), e0193133. https://doi.org/10.1371/journal.pone.0193133
   PubMed Web of Science ®Google Scholar
• Salisch, N. C., Stephenson, K. E., Williams, K., Cox, F., van der Fits, L., Heerwegh, D., Truyers, C., Habets, M. N., Kanjilal, D. G., Larocca, R. A., Abbink, P., Liu, J., Peter, L., Fierro, C., De La Barrera, R. A., Modjarrad, K., Zahn, R. C., Hendriks, J., Cahill, C. P., … Barouch, D. H. (2021). A double-blind, randomized, placebo-controlled phase 1 study of Ad26. ZIKV. 001, an Ad26-vectored anti–Zika virus vaccine. Annals of Internal Medicine, 174(5), 585–594. https://doi.org/10.7326/M20-5306
   PubMed Web of Science ®Google Scholar
• Scheuermann, R. H., Sinkovits, R. S., Schenkelberg, T., & Koff, W. C. (2017). A bioinformatics roadmap for the human vaccines project. Expert Review of Vaccines, 16(6), 535–544. https://doi.org/10.1080/14760584.2017.1322752
   PubMed Web of Science ®Google Scholar
• Shahid, F., Ashfaq, U. A., Javaid, A., & Khalid, H. (2020). Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome. Infection, Genetics and Evolution : journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 80, 104199. https://doi.org/10.1016/j.meegid.2020.104199
   PubMed Web of Science ®Google Scholar
• Shankar, U., Jain, N., Mishra, S. K., Sk, M. F., Kar, P., & Kumar, A. (2022). Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection. Journal of Biomolecular Structure & Dynamics, 40(11), 4815–4831. https://doi.org/10.1080/07391102.2021.1874529
   PubMed Web of Science ®Google Scholar
• Siddique, R., Liu, Y., Nabi, G., Sajjad, W., Xue, M., & Khan, S. (2019). Zika virus potentiates the development of neurological defects and microcephaly: Challenges and control strategies. Frontiers in Neurology, 10, 319. https://doi.org/10.3389/fneur.2019.00319
   PubMed Web of Science ®Google Scholar
• Sippl, M. J., Lackner, P., Domingues, F. S., Prli?, A., Malik, R., Andreeva, A., & Wiederstein, M. (2001). Assessment of the CASP4 fold recognition category. Proteins: Structure, Function, and Genetics, 45(S5), 55–67. https://doi.org/10.1002/prot.10006
   PubMedGoogle Scholar
• Soria-Guerra, R. E., Nieto-Gomez, R., Govea-Alonso, D. O., & Rosales-Mendoza, S. (2015). An overview of bioinformatics tools for epitope prediction: Implications on vaccine development. Journal of Biomedical Informatics, 53, 405–414. https://doi.org/10.1016/j.jbi.2014.11.003
   PubMed Web of Science ®Google Scholar
• Tarrahimofrad, H., Rahimnahal, S., Zamani, J., Jahangirian, E., & Aminzadeh, S. (2021). Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9. Scientific Reports, 11(1), 24485. https://doi.org/10.1038/s41598-021-03932-2
   PubMed Web of Science ®Google Scholar
• UniProt: The universal protein knowledgebase in 2021. (2021). Nucleic Acids Research, 49(D1), D480–D489.
   PubMed Web of Science ®Google Scholar
• Vajda, S., Yueh, C., Beglov, D., Bohnuud, T., Mottarella, S. E., Xia, B., Hall, D. R., & Kozakov, D. (2017). New additions to the C lus P ro server motivated by CAPRI. Proteins, 85(3), 435–444. https://doi.org/10.1002/prot.25219
   PubMed Web of Science ®Google Scholar
• Wang, Y., Ling, L., Zhang, Z., & Marin-Lopez, A. (2022). Current Advances in Zika vaccine development. Vaccines, 10(11), 1816. https://doi.org/10.3390/vaccines10111816
   Web of Science ®Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server issue), W407–W410. https://doi.org/10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Yang, Y., Sun, W., Guo, J., Zhao, G., Sun, S., Yu, H., Guo, Y., Li, J., Jin, X., Du, L., Jiang, S., Kou, Z., & Zhou, Y. (2015). In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Human Vaccines & Immunotherapeutics, 11(3), 795–805. https://doi.org/10.1080/21645515.2015.1012017
   PubMed Web of Science ®Google Scholar
• Zambrano, B., Noriega, F., Dayan, G. H., Rivera, D. M., Arredondo, J. L., Reynales, H., Luz, K., Deseda, C., Bonaparte, M. I., Langevin, E., Wu, Y., Cortés, M., Savarino, S., & DiazGranados, C. A. (2021). Zika and Dengue interactions in the context of a large Dengue Vaccine Clinical Trial in Latin America. The American Journal of Tropical Medicine and Hygiene, 104(1), 136–144. https://doi.org/10.4269/ajtmh.20-0635
   PubMed Web of Science ®Google Scholar
• Zhang, L. (2018). Multi-epitope vaccines: A promising strategy against tumors and viral infections. Cellular & Molecular Immunology, 15(2), 182–184. https://doi.org/10.1038/cmi.2017.92
   PubMed Web of Science ®Google Scholar
• Zhou, K., Li, C., Shi, W., Hu, X., Nandakumar, K. S., Jiang, S., & Zhang, N. (2021). Current progress in the development of Zika virus vaccines. Vaccines, 9(9), 1004. https://doi.org/10.3390/vaccines9091004
   Web of Science ®Google Scholar